Add Formweb to your mobile device
Formulary synchronization in progress.
Please refer to Epic and your local
pharmacy
for available medications.
Search results for:
baloxavir marboxil
baloxavir marboxil
Brand names: Xofluza
| Form | Strength |
|---|---|
| TABLET, ORAL | 20 mg |
Last updated: Dec. 30, 2019
Baloxavir marboxil has been removed from the HM formulary as of 10/2019 due to reports of safety events and anaphylactic shock.
Baloxavir marboxil is currently a non-formulary agent and is unavailable at Houston Methodist.
Serious post market adverse events, including fatal cases of anaphylactic shock, have been reported for baloxavir marboxil (Xofluza®). Due to safety concerns, the System Antimicrobial Stewardship Committee recommends against use of baloxavir in any setting until more risk versus benefit data are available.
ISMP MedWatch Report
Contact pharmacy for further questions.
HM Policy: Restricted to patients (>11 years) unable to tolerate oseltamivir and/or in the setting of emerging oseltamivir resistance as monitored/reported by the CDC